Literature DB >> 3143363

Modulation of polyamine biosynthesis and transport by oncogene transfection.

B K Chang1, P R Libby, R J Bergeron, C W Porter.   

Abstract

The effects of oncogene expression on phenomena related to polyamine metabolism were examined in Rat-1 cells stably transfected with EJ2-ras or N-myc oncogenes. In ras-transfected cells, ornithine decarboxylase activity was about 12-times higher than in either the parent or N-myc-transfected cell lines. By contrast, polyamine uptake was markedly increased in N-myc-transfected cells, as indicated by their enhanced sensitivity to the antiproliferative and enzyme regulatory effects of the polyamine analog, N1, N12-bis(ethyl)spermine (BESm), their intracellular accumulation of BESm and by their increased sensitivity to the growth inhibitory effects of methylglyoxalbis(guanylhydrazone)--another analog which utilizes the polyamine transport mechanism. These associations between N-myc and ras expression and critical aspects of polyamine metabolism suggest a possible role for the latter in facilitating the growth promoting properties of these oncogenes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143363     DOI: 10.1016/s0006-291x(88)80042-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Substrate protection against inactivation of the mammalian polyamine-transport system by 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide.

Authors:  K Torossian; M Audette; R Poulin
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines.

Authors:  B K Chang; R J Bergeron; C W Porter; J R Vinson; Y Liang; P R Libby
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models.

Authors:  B K Chang; R J Bergeron; C W Porter; Y Liang
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Antizyme induction by polyamine analogues as a factor of cell growth inhibition.

Authors:  John L A Mitchell; Aviva Leyser; Michelle S Holtorff; Jill S Bates; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

5.  Expression of a human gene for polyamine transport in Chinese-hamster ovary cells.

Authors:  T L Byers; R Wechter; M E Nuttall; A E Pegg
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

6.  Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.

Authors:  Eric T Alexander; Kelsey Mariner; Julia Donnelly; Otto Phanstiel; Susan K Gilmour
Journal:  Mol Cancer Ther       Date:  2020-08-03       Impact factor: 6.261

7.  Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal.

Authors:  A E Proudfoot; S C Brown; A R Bernard; J Y Bonnefoy; E H Kawashima
Journal:  J Protein Chem       Date:  1993-08

8.  ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Authors:  Meenu Madan; Arjun Patel; Kristen Skruber; Dirk Geerts; Deborah A Altomare; Otto Phanstiel Iv
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

9.  A novel polyamine blockade therapy activates an anti-tumor immune response.

Authors:  Eric T Alexander; Allyson Minton; Molly C Peters; Otto Phanstiel; Susan K Gilmour
Journal:  Oncotarget       Date:  2017-08-24

10.  A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors.

Authors:  Molly C Peters; Allyson Minton; Otto Phanstiel Iv; Susan K Gilmour
Journal:  Med Sci (Basel)       Date:  2018-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.